Edward Nash
Stock Analyst at Canaccord Genuity
(1.94)
# 1047
Out of 5,329 analysts
105
Total ratings
32.65%
Success rate
31.53%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CLDX Celldex Therapeutics | Initiates Coverage On: Buy | 64 | 21.01 | 204.62% | 1 | Apr 28, 2025 | |
TVTX Travere Therapeutics | Maintains: Strong Buy | 45 47 | 20.39 | 130.51% | 10 | Apr 10, 2025 | |
CORT Corcept Therapeutics | Maintains: Strong Buy | 130 142 | 72.32 | 96.35% | 7 | Apr 1, 2025 | |
RANI Rani Therapeutics Hl... | Maintains: Buy | 9 9 | 1.07 | 741.12% | 2 | Feb 26, 2025 | |
VRNA Verona Pharma | Maintains: Strong Buy | 44 72 | 72.53 | -0.73% | 9 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 4 | 1.64 | 143.9% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 56 73 | 45.48 | 60.51% | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 89 | 40.24 | 121.17% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 14 | 1.41 | 892.91% | 6 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 8 | 1.14 | 601.75% | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 20 | 3.5 | 471.43% | 2 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 338 377 | 337.52 | 11.7% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 68 66 | n/a | n/a | 2 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 19 | n/a | n/a | 9 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Hold | 8 | 2.9 | 175.86% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 71 48 | n/a | n/a | 3 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 17 | 3.96 | 329.29% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3 2 | 2.33 | -14.16% | 4 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 17 | n/a | n/a | 2 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 900 180 | 1.27 | 14073.23% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 52 | n/a | n/a | 2 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | n/a | n/a | 1 | Apr 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 1 | n/a | n/a | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 82 | 39.87 | 105.67% | 5 | Jun 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 120 80 | 3.53 | 2166.29% | 3 | Sep 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 3 | n/a | n/a | 1 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Oct 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 48 | 15.17 | 216.41% | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 650 | 7.06 | 9106.8% | 1 | Nov 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 150 0 | n/a | n/a | 3 | Sep 22, 2017 |